CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 71 filers reported holding CHEMOCENTRYX INC in Q1 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $586,000 | +73.9% | 62,640 | +35.2% | 0.02% | +88.9% |
Q1 2017 | $337,000 | +355.4% | 46,330 | +277.1% | 0.01% | +350.0% |
Q3 2015 | $74,000 | -77.4% | 12,287 | -69.2% | 0.00% | -77.8% |
Q2 2015 | $328,000 | +81.2% | 39,882 | +66.6% | 0.01% | +80.0% |
Q1 2015 | $181,000 | – | 23,940 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |